HKMPF and HIK:LN Related Headlines
Go Back- Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP20.50 at Deutsche Bank
- Citi Starts Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) at Buy
- Barclays Reiterates Underweight Rating on Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF)
- Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Raised to GBP1,870 at Jefferies
- Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP18 at Berenberg
- Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP20 at JPMorgan
- Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP13.50 at Barclays
- Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP24 at Deutsche Bank
- Barclays Downgrades Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) to Underweight
- Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP25 at Deutsche Bank
- Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP23 at Berenberg
- Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP21 at Barclays
- Deutsche Bank Reiterates Buy Rating on Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF)
- Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP25.10 at Berenberg
- Hikma Pharmaceuticals Plc (HIK:LN) (HKMPF) PT Lowered to GBP28.50 at Deutsche Bank

